Search Results - "Zirlik, A."

Co-stimulatory molecules in and beyond co-stimulation - tipping the balance in atherosclerosis? by Gerdes, N, Zirlik, A

“…A plethora of basic laboratory and clinical studies has uncovered the chronic inflammatory nature of atherosclerosis. The adaptive immune system with its…”
Get more information

Diet-induced obesity requires signalling through tumor necrosis factor receptor-associated factor 1 (TRAF-1) in adipocytes by Wolf, D, Michel, N. Anto, Hilgendorf, I, Bode, Zirlik, A

Get full text

Inflammatory mechanisms in atherosclerosis by Wolf, D, Stachon, P, Bode, C, Zirlik, A

“…Throughout the last two decades inflammation has been recognized as the central mechanism underlying atherogenesis. A multitude of basic science work…”
Get more information

Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile by Merz, J., Nettesheim, A., von Garlen, S., Albrecht, P., Saller, B. S., Engelmann, J., Hertle, L., Schäfer, I., Dimanski, D., König, S., Karnbrock, L., Bulatova, K., Peikert, A., Hoppe, N., Hilgendorf, I., von zur Mühlen, C., Wolf, D., Groß, O., Bode, C., Zirlik, A., Stachon, P.

“…Extracellular nucleotides act as danger signals that orchestrate inflammation by purinergic receptor activation. The expression pattern of different purinergic…”
Get full text

An inflammatory link in atherosclerosis and obesity. Co-stimulatory molecules by Zirlik, A, Lutgens, E

“…Atherosclerosis and obesity-induced metabolic dysfunction are lipid-driven inflammatory pathologies responsible for a major part of cardiovascular…”
Get more information

Towards a Cardiac Allocation Score: A Retrospective Calculation for 73 Patients from a German Transplant Center by Grundmann, S, Claes, S, Berchtold-Herz, M, Zhou, Q, Trummer, G, Zirlik, A, Beyersdorf, F, Bode, C

Get full text

CHEMICAL RENAL DENERVATION WITH ALCOHOL – LONG TERM RESULTS FROM THE PEREGRINE POST-MARKET STUDY by Persu, A, Renkin, J, Hochul, M, Wojakowski, W, Böhm, M, Mahfoud, F, Schmieder, R, van der Giet, M, de Bucourt, M, Zirlik, A, Neuzil, P, Haratani, N, Parise, H, Fischell, T, Bertog, S, Sievert, K, Sievert, H

“…OBJECTIVE:The Peregrine post-market study is a prospective, single arm, open label, multicenter European trial evaluating the safety and performance of the…”
Get full text

Acute exposure to air pollution aggravates acute myocardial infarction and subsequent ischemic heart failure in mice by Wolf, D, Marchini, T, Anto Michel, N, Dürschmied, D, Hilgendorf, I, Bode, C, Zirlik, A

Get full text

Early atheroprotection by SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression by Lindau, A, Haerdtner, C, Swirski, F.K, Libby, P, Hein, L, Bode, C, Zirlik, A, Hilgendorf, I

Get full text

Anticoagulation during and after acute coronary syndrome by Ahrens, I, Bode, C, Zirlik, A

“…Current antithrombotic therapy in patients with acute coronary syndrome (ACS) comprises antiplatelet and anticoagulant therapy. Dual antiplatelet therapy…”
Get more information

Dual targeting improves capture of ultrasound microbubbles towards activated platelets but yields no additional benefit for imaging of arterial thrombosis by Günther, F., Heidt, T., Kramer, M., Khanicheh, E., Klibanov, A. L., Geibel-Zehender, A., Ferrante, E. A., Hilgendorf, I., Wolf, D., Zirlik, A., Reinöhl, J., Bode, C., Peter, K., Kaufmann, B. A., Mühlen, C. von zur

“…Platelets can be found on the surface of inflamed and ruptured atherosclerotic plaques. Thus, targeting of activated platelets may allow for molecular imaging…”
Get full text

Asymptomatic atrial fibrillation and risk of stroke by Stachon, P, Ahrens, I, Faber, T, Bode, C, Zirlik, A

“…The incidence of atrial fibrillation rises with advancing age. About 10% of patients over 80 years suffer from atrial fibrillation, but episodes are often not…”
Get more information

STEMI and NSTEMI: the dangerous brothers by Bode, Christoph, Zirlik, Andreas

Get full text

Astaxanthin: An anti-atherosclerotic treatment in mice by Anto-Michel, N., Mächler, H., Zirlik, A.

Get full text

Massive air embolism after Maze by Zirlik, A, Nordt, T K

“…[...]an oesophagoatrial fistula was diagnosed by oesophagoscopy and palliative stenting was performed…”
Get full text

Prediction of cardiovascular outcomes by subtle changes in the peripheral immune cell landscape - insights from the LURIC single cell RNA-sequencing study (LuRNA) by Horstmann, H, Anto Michel, N, Westermann, D, Maerz, W, Zirlik, A, Wolf, D

“…Abstract Background and Aims Atherosclerosis and its clinical sequelae, myocardial infarction and stroke, represent the main causes of death worldwide…”
Get full text

Real world cardiovascular risk assessment using reduced DAD, SCORE and Framingham equations in a German HIV cohort by Zhou, Q, Usadel, S, Kern, W, Zirlik, A, Mueller, M.C

“…Abstract Introduction People living with HIV are at increased risk for cardiovascular disease (CVD). Therefore, prevention of CVD should be integrated in HIV…”
Get full text

Electrophysiological findings, incidence, and predictors for AF recurrence after pulsed field versus radiofrequency pulmonary vein isolation. A retrospective analysis by Eberl, A, Manninger, M, Rohrer, U, Reischl, A, Zirlik, A, Scherr, D

“…Abstract Background Pulsed field ablation (PFA) is an emerging method for catheter ablation of atrial fibrillation (AF). Data comparing efficacy and safety of…”
Get full text

Post-processing measurement of left ventricular ejection fraction compared to direct measurement in patients with heart failure with reduced ejection fraction by Schwegel, N, Kolesnik, E, Toth-Gayor, G, Zirlik, A, Von Lewinski, D, Ablasser, K, Verheyen, N

“…Abstract Introduction Left ventricular ejection fraction (LVEF) derived from transthoracic echocardiography (TTE) is routinely used to guide therapeutic…”
Get full text

Left atrial reservoir strain differentiates cardiac amyloidosis and hypertrophic cardiomyopathy by Winkelbauer, L, Santner, V, Schwegel, N, Hoeller, V, Gollmer, J, Kolesnik, E, Wallner, M, Von Lewinski, D, Zirlik, A, Ablasser, K, Verheyen, N, Zach, D

“…Abstract Aims Availability of mortality-reducing therapies for cardiac amyloidosis (CA) has led to an increase in referral rates to tertiary care centers…”
Get full text